72903-0853 ELAHERE - CanMED: NDC

Product NDC:

72903-0853

Brand Name:

ELAHERE

Generic Name:

Mirvetuximab soravtansine

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Substances:

Name: MIRVETUXIMAB SORAVTANSINE

Strength: 5.0

Unit: mg/mL

Packages:

Code: 72903-0853-01

Description: 1 VIAL, SINGLE-USE in 1 CARTON (72903-853-01) / 20 mL in 1 VIAL, SINGLE-USE

Effective Date: Nov. 14, 2022

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Drug Antibody Conjugate

Minor Class:

FR-alpha, DM4

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox